Prescription drug · NDA
Zypitamag (pitavastatin magnesium) NDC 70771-1117
Pitavastatin 2 mg/1 · Tablet, Film coated · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1117-0 | 70771111700 | 1000 TABLET, FILM COATED in 1 BOTTLE (70771-1117-0)Marketed from Mar 9, 2018 | |
| 70771-1117-1 | 70771111701 | 100 TABLET, FILM COATED in 1 BOTTLE (70771-1117-1)Marketed from Mar 9, 2018 | |
| 70771-1117-3 | 70771111703 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1117-3)Marketed from Mar 9, 2018 | |
| 70771-1117-4 | 70771111704 | 10 BLISTER PACK in 1 CARTON (70771-1117-4) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Mar 9, 2018 | |
| 70771-1117-5 | 70771111705 | 500 TABLET, FILM COATED in 1 BOTTLE (70771-1117-5)Marketed from Mar 9, 2018 | |
| 70771-1117-7 | 70771111707 | 1 BLISTER PACK in 1 CARTON (70771-1117-7) / 7 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Mar 9, 2018 | |
| 70771-1117-9 | 70771111709 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1117-9)Marketed from Mar 9, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zypitamag
- Generic name (nonproprietary)
- pitavastatin magnesium
- Active ingredients
- Pitavastatin — 2 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208379
- Marketing start
- Listing expires
- Other FDA classes
- Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1117_8eab99e7-f5e0-4b8a-8cc6-2d90618ebf93SPL ID 8eab99e7-f5e0-4b8a-8cc6-2d90618ebf93SPL set ID e9f0fe3a-0462-4c24-8f22-3c89afe8fceaRxCUI 2001262, 2001264, 2001266, 2001268UNII M5681Q5F9P
- Pharmacologic class
- HMG-CoA Reductase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771111700followed by a unit qualifier and the quantityPackage 70771-1117-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under NDA 208379
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Zypitamagpitavastatin magnesium | Pitavastatin 2 mg/1 | Tablet, Film coatedOral | Medicure International Inc | 25208-201 |
| Zypitamagpitavastatin magnesium | Pitavastatin 4 mg/1 | Tablet, Film coatedOral | Medicure International Inc | 25208-202 |
| Zypitamagpitavastatin magnesium | Pitavastatin 4 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1118 |